Billerica, MA—August 22, 2014—EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, announces that EMD Millipore and Samsung BioLogics have signed an MOU (Memorandum of Understanding) for a strategic alliance on the biopharmaceutical business. The alliance is intended to encompass a long-term supply agreement in which EMD Millipore will provide raw materials for biopharmaceutical manufacturing. Dr. Udit Batra, President and CEO of EMD Millipore, and Benoit Gourdier, head of EMD Millipore’s Process Solutions Asia, were present at the signing…